Diarrheal disease from drinking unsafe water is one of the leading causes of death in Mexico. Today, millions of Mexicans in low-income communities are still at high risk of waterborne diseases because of inadequate water infrastructure and insufficient water quality control. In particular, safe water remains unavailable to those who cannot afford commercially sold bottled water. Water technology like the UV Tube, developed through collaboration between UC Berkeley and Fundacion Cantaro Azul, is an effective means to secure water quality at home. Nuestra Agua, a new social franchise designed by UC Berkeley students, will expand on the UV Tube project and offer a local, affordable, and reliable option for people who need to purchase safe water as well as an economic opportunity for local entrepreneurs.
(Note: This project originally won in the Big Ideas “Social Entrepreneurship” category.)
Currently, about 140 million rural mountain inhabitants lack access to an improved water source. Consequently, there is an urgent need to find an efficient solution to supply safe water to these populations by further developing the delivery of piped water. Piped water is necessary to conveniently supply the water volume required to meet personal and household hygiene and consumption needs. Unfortunately, willingness to pay for water is traditionally low, and sustainable financing of the necessary water supply infrastructure is known to be very challenging. Power for Water will overcome this obstacle by implement an innovative combination of policy and technology. Specifically, the project combines a proven infrastructure synergy and an efficient public-private partnership to sustainably address the lack of access to safe water and electricity in rural mountainous regions of the world. By overcome the technological and institutional barriers currently preventing millions of people from access to clean, reliable water, this project will improve the lives of millions of people living in remote mountain regions.
Dengue virus causes the most common mosquito-borne viral disease affecting humans, with 3 billion people at risk for infection and an estimated 50 million cases each year. The goal of this project is to prevent severe illness and death from dengue through the use of a portable method in the field to identify the most at-risk patients. The first part of the project will develop risk scores to predict which patients presenting with fever in dengue-endemic areas are infected with dengue virus and of those infected, who will progress to develop severe dengue. In order for the risk scores to be used effectively in the field, the project team will also develop a mobile application for the iPhone that will enable any health professional to instantly calculate a patient’s risk score. The iPhone risk score application will enable physicians to distinguish dengue cases from cases of other illnesses that cause fever, as well as mild dengue cases from severe dengue cases, so they can provide patients with the appropriate medical care sooner. Additionally, it will help physicians prioritize the treatment of dengue cases in lowresource settings, where medical care and supplies are limited.
Diarrheal disease from drinking unsafe water is one of the leading causes for death in Mexico. Today, millions of Mexicans in low-income communities are still at high risk of waterborne diseases because of inadequate water infrastructure and insufficient water quality control. In particular, safe water remains unavailable to those who cannot afford commercially sold bottled water. Point of use water technology like the UV Tube, developed through a collaboration between UC Berkeley and Fundacion Cantaro Azul, is an effective means to secure water quality at home. Nuestra Agua, a new social franchise designed by UC Berkeley students, will expand on the UV Tube project and offer a local, affordable, and reliable option for people who need to purchase safe water and an economic opportunity for local entrepreneurs. (Note: This project originally won in the Big Ideas “Safe Water Enterprise” category.)
Malaria is a disease endemic to regions of South America, Sub-Saharan Africa, and South Asia that continues to do serious humanitarian and economic damage to developing countries. A new diagnostic tool (the MOT device) has recently been invented that would improve access to accurate malaria diagnosis at low costs. To collect information on the best way to bring these devices to the communities that need it, we propose a fact-finding pilot program to provide MOTmalaria diagnosis and treatment centers to 25,000 people in Southern Benin. (Note: This project originally won in the Big Ideas “Science, Technology, and Engineering Policy” category.)
Rising healthcare spending is a serious issue for the United States. Electronic medical records are seen as an effective way to solve the problem, however they are difficult to implement. We propose the development of personal portable healthcare record smart cards and a corresponding framework to simplify maintenance and transfer of patient records as an incremental step towards a nationalized electronic records system. (Note: This project originally won in the Big Ideas “Science, Technology, and Engineering Policy” category.)
The study will evaluate the performance of the OSOM® Trichomonas Rapid Test for the detection of trichomoniasis in women from rural and peri-urban areas of Mysore, India, in comparison to PCR, culture and wet-mount preparation.
In Northern India, nearly 60% of viral hepatitis in pregnant women is attributed to hepatitis E infection (HEV). Given the growing rates of HEV in South Asia and the hypothesis that levels of hormones may affect disease severity in pregnant women with HEV, this study proposes a cross-sectional approach to examine estriol levels and seroprevalence of anti-HEV (IgG and IgM) in village dwellers in Uttar Pradesh, India.
Parasitic worms infect over 1 billion people in the developing world today, yet the treatments are inexpensive. For people infected with worms, taking these medications can improve school attendance and performance, but little is known about the long-term gain from de-worming treatment early in life. In my study this summer, I aim to collect data to answer exactly that question, in the context of de-worming interventions that took place in East Africa from 1998-2001.
